News Conference News TCT 2019 Predicting Final Valve Position After TAVR: Different Devices, Different Success Michael O'Riordan October 07, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
Presentation TCT 2019 TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials Presenter: Robert Bonow September 28, 2019
News Conference News TCT 2019 Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients Yael L. Maxwell September 27, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019
Presentation TCT 2019 Remaining Data Gaps After the Low-Risk TAVR RCTs Presenter: Michael Borger September 26, 2019
Presentation TCT 2019 Deep-Dive: NEW Insights From the Evolut Low-Risk Trial Presenter: Michael Reardon September 26, 2019
News Conference News TCT 2019 Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease Michael O'Riordan September 25, 2019
Presentation TCT 2019 TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions Presenter: Toby Rogers September 25, 2019
Presentation TCT 2019 The Clinical Evidence: Extreme- to Low-Risk Patients Presenter: Michael Reardon September 25, 2019